H.R.1840: Reinvigorating Antibiotic and Diagnostic Innovation Act of 2017

About This Bill

Bill Version

Bill Summary

Reinvigorating Antibiotic and Diagnostic Innovation Act of 2017 This bill amends the Internal Revenue Code to allow tax credits for 50% of the clinical testing expenses for: (1) infectious disease products that are intended to treat a serious or life-threatening infection, including one caused by an antibacterial or antifungal resistant pathogen or a qualifying pathogen listed by the Department of Health and Human Services as having the...

(Source: Library of Congress)

Bill Actions

Date Description
March 30, 2017
Referred to the House Committee on Ways and Means.
March 30, 2017

Introduced in the House by Erik Paulsen (R-Minn.)

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page